Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $26.8100 (-2.47%) ($26.3500 - $27.8600) on Mon. Oct. 22, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.1% (three month average) | RSI | 42 | Latest Price | $26.8100(-2.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -0.8% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(62%) XBI(61%) IWO(59%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -1.55% in a week (0% probabilities). VXX(-13%) VIXM(-11%) TLT(-5%) SHY(-5%) GDXJ(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.55% (StdDev 3.1%) | Hourly BBV | 0 () | Intraday Trend | -2.8% | | | |
|
Resistance Level | $28.91 | 5 Day Moving Average | $28.25(-5.1%) | 10 Day Moving Average | $27.62(-2.93%) | 20 Day Moving Average | $28.91(-7.26%) | To recent high | -24.2% | To recent low | 3.2% | Market Cap | $1.665b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |